Literature DB >> 19861190

Pepsin as a causal agent of inflammation during nonacidic reflux.

Tina L Samuels1, Nikki Johnston.   

Abstract

OBJECTIVE: To investigate the contribution of pepsin to inflammation attributed to nonacidic gastric reflux via analysis of inflammatory cytokine and cytokine receptor gene expression in pepsin-treated human hypopharyngeal epithelial cells in vitro. STUDY
DESIGN: Translational research.
SETTING: This study was performed in an academic research laboratory. SUBJECTS AND METHODS: Human hypopharyngeal epithelial cells were incubated with or without pepsin (0.1 mg/mL) at pH 7.4, 37 degrees C, overnight. Expression of 84 inflammatory cytokines and cytokine receptors was analyzed via RT(2) qPCR array.
RESULTS: Expression of a number of inflammatory cytokines and receptors was altered in human hypopharyngeal epithelial cells following overnight treatment with pepsin at neutral pH. Greater than 1.5-fold change in gene expression was detected for CCL20, CCL26, IL8, IL1F10, IL1A, IL5, BCL6, CCR6, and CXCL14 (P < 0.05).
CONCLUSION: Exposure of hypopharyngeal cells to pepsin in a nonacidic environment induces the expression of several pro-inflammatory cytokines and receptors, including those known to be involved in inflammation of esophageal epithelium in response to reflux and which contribute to the pathophysiology of reflux esophagitis. These data indicate that refluxed pepsin may contribute to laryngeal inflammation associated with nonacidic gastric reflux, including that experienced by patients despite maximal acid suppression therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19861190     DOI: 10.1016/j.otohns.2009.08.022

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  28 in total

1.  Loss of alkalization in proximal esophagus: a new diagnostic paradigm for patients with laryngopharyngeal reflux.

Authors:  Shahin Ayazi; Jeffrey A Hagen; Joerg Zehetner; Matt Lilley; Priyanka Wali; Florian Augustin; Arzu Oezcelik; Helen J Sohn; John C Lipham; Steven R Demeester; Tom R DeMeester
Journal:  J Gastrointest Surg       Date:  2010-09-11       Impact factor: 3.452

2.  Upper esophageal and pharyngeal cancers.

Authors:  Jonathan M Bock; Amy B Howell; Nikki Johnston; Laura A Kresty; Daniel Lew
Journal:  Ann N Y Acad Sci       Date:  2014-09       Impact factor: 5.691

3.  Letter to the Editor: Acid Reflux or Non-acid Reflux?

Authors:  Yushuang Xu; Cuiping Zhang
Journal:  Dig Dis Sci       Date:  2018-10-01       Impact factor: 3.199

4.  Acidic Pharyngeal Reflux Does Not Correlate with Symptoms and Laryngeal Injury Attributed to Laryngopharyngeal Reflux.

Authors:  Martin Duricek; Peter Banovcin; Tatiana Halickova; Rudolf Hyrdel; Marian Kollarik
Journal:  Dig Dis Sci       Date:  2018-11-14       Impact factor: 3.199

Review 5.  [Extraesophageal reflux. Overview and discussion of a new method for pH monitoring].

Authors:  M Jungheim; M Ptok
Journal:  HNO       Date:  2011-09       Impact factor: 1.284

Review 6.  How to Approach Laryngopharyngeal Reflux: An Otolaryngology Perspective.

Authors:  Vaninder K Dhillon; Lee M Akst
Journal:  Curr Gastroenterol Rep       Date:  2016-08

7.  Immunoserologic pepsin detection in the saliva as a non-invasive rapid diagnostic test for laryngopharyngeal reflux.

Authors:  Emre Ocak; Gözde Kubat; İrfan Yorulmaz
Journal:  Balkan Med J       Date:  2015-01-01       Impact factor: 2.021

Review 8.  Extra-esophageal manifestations of gastroesophageal reflux disease: diagnosis and treatment.

Authors:  Christopher Hom; Michael F Vaezi
Journal:  Drugs       Date:  2013-08       Impact factor: 9.546

9.  In vivo investigation of acidified pepsin exposure to porcine vocal fold epithelia.

Authors:  Abigail Durkes; M Preeti Sivasankar
Journal:  Laryngoscope       Date:  2015-07-07       Impact factor: 3.325

10.  New developments in extraesophageal reflux disease.

Authors:  Elif Saritas Yuksel; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.